naltrexone and resiniferatoxin

naltrexone has been researched along with resiniferatoxin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, SR; Pan, HL	1
Athayde, ML; Boligon, AA; Bonacorso, HG; Calixto, JB; Ferreira, J; Machado, P; Martins, MA; Oliveira, SM; Rosa, F; Rossato, MF; Rubin, MA; Silva, CR; Tonello, R; Trevisan, G; Walker, CI; Zanatta, N	1

Other Studies

2 other study(ies) available for naltrexone and resiniferatoxin

Article	Year
Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception. Neuropharmacology, 2008, Volume: 55, Issue:2 Topics: Analgesics, Opioid; Analysis of Variance; Animals; Behavior, Animal; Diterpenes; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Gene Expression Regulation; Hyperalgesia; Male; Naltrexone; Oligopeptides; Pain Threshold; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Sensory Receptor Cells; Spinal Cord; Tritium; TRPV Cation Channels	2008
A novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptors. Neuropharmacology, 2013, Volume: 73 Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Benzofurans; Diterpenes; Drug Administration Routes; Drug Evaluation, Preclinical; Idazoxan; Male; Mice; Molecular Structure; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Pyrazoles; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa; Tritium; TRPV Cation Channels	2013

Article

Year

Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception.

Neuropharmacology, 2008, Volume: 55, Issue:2

Topics: Analgesics, Opioid; Analysis of Variance; Animals; Behavior, Animal; Diterpenes; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Gene Expression Regulation; Hyperalgesia; Male; Naltrexone; Oligopeptides; Pain Threshold; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Sensory Receptor Cells; Spinal Cord; Tritium; TRPV Cation Channels

2008

A novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptors.

Neuropharmacology, 2013, Volume: 73

Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Benzofurans; Diterpenes; Drug Administration Routes; Drug Evaluation, Preclinical; Idazoxan; Male; Mice; Molecular Structure; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Pyrazoles; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa; Tritium; TRPV Cation Channels

2013